A second-generation synthetic antisense oligonucleotide with potential antineoplastic activity. AEG35156 selectively blocks the cellular expression of X-linked inhibitor of apoptosis protein (XIAP), a pivotal inhibitor of apoptosis that is overexpressed in many tumors. This agent reduces total levels of XIAP in tumor cells, working synergistically with cytot...
Investigated for use/treatment in cancer/tumors (unspecified) and leukemia (myeloid).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.